EDUCATION CENTER

TRT Monitoring: What Should You Test After Starting Testosterone?

Follow-up labs and visits that keep therapy in a physiologic range.

What should you test after starting testosterone?

Typical follow-up includes a testosterone level drawn at the correct time for your product, a CBC for hematocrit, blood pressure, and a symptom review. PSA is repeated when it was part of baseline screening. Estradiol is checked when gynecomastia, water retention, or low libido despite mid-range T suggests it would change the plan.

Sleep, injection or gel technique, and missed doses are part of monitoring even though they are not lab tests. A “perfect” trough with worsening apnea still needs action.

When are the first follow-up labs?

Many protocols recheck in roughly 6–12 weeks after a start or a dose change, then space visits out once you are stable. Injections are often interpreted at trough (before the next shot). Gels have product-specific windows.

After a formulation switch, treat it like a new start: do not wait a year to see whether hematocrit climbed.

What is the target testosterone level on TRT?

The target is a mid-normal physiologic range that matches how you feel — not the top of the reference interval at all costs. Guidelines caution against chasing supraphysiologic peaks. Hematocrit remaining in a safe range can cap how high the dose goes.

FAQs

Do I need labs forever on TRT?

Yes, though less often once you are stable. Dose changes, new symptoms, or rising hematocrit bring labs forward again.

What if my hematocrit is high?

Your clinician may lower the dose, change frequency or formulation, evaluate sleep apnea, or in some cases discuss therapeutic phlebotomy. Do not donate blood as a workaround without medical guidance.

References

  1. 1. Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744.

  2. 2. Mulhall JP, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432.

  3. 3. Lincoff AM, et al. Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE). N Engl J Med. 2023;389:107-117.

  4. 4. U.S. Food and Drug Administration. Testosterone Information.

  5. 5. Bhasin S, et al. Testosterone Replacement in Aging Men: An Endocrine Society Scientific Statement. J Clin Endocrinol Metab.

Related guides

Ready to talk with a Vita Bella provider?

Start a membership consultation so a licensed Vita Bella provider can review your symptoms, labs, and whether testosterone therapy is appropriate for you.